{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:20:44Z","timestamp":1783444844687,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:00:00Z","timestamp":1795219200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR079428"],"award-info":[{"award-number":["R01 AR079428"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 GM136815"],"award-info":[{"award-number":["R01 GM136815"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jid.2025.04.025","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:28:48Z","timestamp":1747250928000},"page":"3158-3173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Triple-Action Inhibitory Mechanism of Allosteric TYK2-Specific Inhibitors"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-8038","authenticated-orcid":false,"given":"Jimin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-5068","authenticated-orcid":false,"given":"Ivan B.","family":"Lomakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-1237","authenticated-orcid":false,"given":"Victor S.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-8308","authenticated-orcid":false,"given":"Christopher G.","family":"Bunick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.025_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3beta homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.04.025_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jid.2025.04.025_bib3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s13555-023-00986-0","article-title":"The prevalent comorbidome at the onset of psoriasis diagnosis","volume":"13","author":"Buja","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.04.025_bib4","doi-asserted-by":"crossref","first-page":"eaaw1736","DOI":"10.1126\/scitranslmed.aaw1736","article-title":"Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain","volume":"11","author":"Burke","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2025.04.025_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112201","article-title":"Structural basis of Janus kinase trans-activation","volume":"42","author":"Caveney","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2025.04.025_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","article-title":"Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA","volume":"93","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.04.025_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 synergize to promote MAIT cell IL-17A and IL-17F production independently of IL-23 signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.025_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from pathogenesis to targeted therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2025.04.025_bib9","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1111\/febs.16116","article-title":"The role of understudied post-translational modifications for the behavior and function of signal transducer and activator of transcription 3","volume":"289","author":"Diallo","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2025.04.025_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ced\/llad188","article-title":"Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review","volume":"48","author":"Dogra","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.025_bib11","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D"},{"key":"10.1016\/j.jid.2025.04.025_bib12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/cancers11111815","article-title":"Nucleocytoplasmic shuttling of STATs. A Target for Intervention?","volume":"11","author":"Ernst","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2025.04.025_bib13","first-page":"1329","article-title":"tyk2, prototype of a novel class of non-receptor tyrosine kinase genes","volume":"5","author":"Firmbach-Kraft","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2025.04.025_bib14","doi-asserted-by":"crossref","first-page":"20494","DOI":"10.1074\/jbc.271.34.20494","article-title":"Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase","volume":"271","author":"Gauzzi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2025.04.025_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.abn8933","article-title":"Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation","volume":"376","author":"Glassman","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jid.2025.04.025_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/j.1460-2075.1994.tb06422.x","article-title":"Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91)","volume":"13","author":"Greenlund","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2025.04.025_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","article-title":"The protein kinase family: conserved features and deduced phylogeny of the catalytic domains","volume":"241","author":"Hanks","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jid.2025.04.025_bib18","first-page":"1347","article-title":"JAK2, a third member of the JAK family of protein tyrosine kinases","volume":"7","author":"Harpur","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2025.04.025_bib19","first-page":"277","article-title":"Identification and chromosomal mapping of new human tyrosine kinase genes","volume":"5","author":"Krolewski","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2025.04.025_bib20","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1038\/s41467-020-17920-z","article-title":"Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains","volume":"11","author":"La Sala","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.04.025_bib21","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1073\/pnas.1611228113","article-title":"Structural basis for DNA recognition by STAT6","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2025.04.025_bib22","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/art.41906","article-title":"A decade of JAK inhibitors: what have we learned and what may be the future?","volume":"73","author":"Liu","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2025.04.025_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/acsmedchemlett.9b00035","article-title":"Identification of imidazo[1,2-b]pyridazine derivatives as potent, selective, and orally active Tyk2 JH2 inhibitors","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jid.2025.04.025_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129235","article-title":"Design, synthesis and biological evaluation of novel N-(methyl-d3) pyridazine-3-carboxamide derivatives as TYK2 inhibitors","volume":"86","author":"Liu","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jid.2025.04.025_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jid.2024.10.594","article-title":"Practical guide for implementing cryogenic electron microscopy structure determination in dermatology research","volume":"145","author":"Lomakin","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.025_bib26","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2025.04.025_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Interleukin 17A: toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.025_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2005.02.021","article-title":"Structural bases of unphosphorylated STAT1 association and receptor binding","volume":"17","author":"Mao","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2025.04.025_bib29","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1111\/j.1432-1033.2004.04423.x","article-title":"Nucleocytoplasmic shuttling of STAT transcription factors","volume":"271","author":"Meyer","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jid.2025.04.025_bib30","doi-asserted-by":"crossref","first-page":"27261","DOI":"10.1074\/jbc.M115.672048","article-title":"Structural and functional characterization of the JH2 pseudokinase domain of JAK family tyrosine kinase 2 (TYK2)","volume":"290","author":"Min","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2025.04.025_bib31","doi-asserted-by":"crossref","first-page":"40782","DOI":"10.1074\/jbc.M507682200","article-title":"Structure of the unphosphorylated STAT5a dimer","volume":"280","author":"Neculai","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2025.04.025_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jid.2025.04.025_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/83028","article-title":"Mechanism-based design of a protein kinase inhibitor","volume":"8","author":"Parang","year":"2001","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jid.2025.04.025_bib34","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.04.025_bib35","article-title":"Innate cells: the alternative source of IL-17 in axial and peripheral spondyloarthritis?","volume":"11","author":"Rosine","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.025_bib36","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/JIR.S380686","article-title":"TYK2 in immune responses and treatment of psoriasis","volume":"15","author":"Shang","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jid.2025.04.025_bib37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jid.2025.04.025_bib38","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/eji.202048922","article-title":"JAK inhibitors: ten years after","volume":"51","author":"Spinelli","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2025.04.025_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2025.04.025_bib40","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1074\/jbc.M114.619502","article-title":"Tyrosine kinase 2-mediated signal transduction in T lymphocytes is blocked by pharmacological stabilization of its pseudokinase domain","volume":"290","author":"Tokarski","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2025.04.025_bib41","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.3390\/ijms21176401","article-title":"The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis","volume":"21","author":"Tsukazaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.025_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nsmb.2807","article-title":"Structural basis of recognition of interferon-\u03b1 receptor by tyrosine kinase 2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jid.2025.04.025_bib43","first-page":"2057","article-title":"Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase","volume":"11","author":"Wilks","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2025.04.025_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D"},{"key":"10.1016\/j.jid.2025.04.025_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/370153a0","article-title":"Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells","volume":"370","author":"Witthuhn","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.04.025_bib46","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.jmedchem.9b00444","article-title":"Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165","volume":"62","author":"Wrobleski","year":"2019","journal-title":"J Med Chem"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:30:59Z","timestamp":1778632259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022202X25004749"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.025","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.09.561507","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Triple-Action Inhibitory Mechanism of Allosteric TYK2-Specific Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}